Allorecognition and the alloresponse: clinical implications.
about
Targeting the Innate Immune Response to Improve Cardiac Graft Recovery after Heart Transplantation: Implications for the Donation after Cardiac DeathCurrent trends in platelet transfusions practice: The role of ABO-RhD and human leukocyte antigen incompatibilityAutoimmune Liver Disease Post-Liver Transplantation: A Summary and Proposed Areas for Future ResearchStructural Basis for T Cell Alloreactivity among Three HLA-B14 and HLA-B27 AntigensHigh-resolution, noninvasive longitudinal live imaging of immune responsesEx vivo generation of human alloantigen-specific regulatory T cells from CD4(pos)CD25(high) T cells for immunotherapyPredicting alloreactivity in transplantation.Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells.Face transplantation: on the verge of becoming clinical routine?Biomarkers of tolerance: searching for the hidden phenotypeHIV-Specific CD8(+) T Lymphocytes in Blood of Long-Term HIV-Infected Hemophilia Patients.Manipulating the immune system for anti-tumor responses and transplant tolerance via mixed hematopoietic chimerism.Pathways of major histocompatibility complex allorecognition.A chromosome 16 quantitative trait locus regulates allogeneic bone marrow engraftment in nonmyeloablated mice.Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organsReview article: bone transplantation and immune response.Old game, new players: Linking classical theories to new trends in transplant immunology.Role of T cells in graft rejection and transplantation tolerance.Roles and mechanism of natural killer cells in clinical and experimental transplantation.Cell therapy to promote transplantation tolerance: a winning strategy?Clinical relevance of the HLA system in blood transfusion.Advances in direct T-cell alloreactivity: function, avidity, biophysics and structure.Relevance of regulatory T cell promotion of donor-specific tolerance in solid organ transplantation.Immunomodulating therapy in liver transplantation: principles and practice.Post-transplant liver biopsy and the immune response: lessons for the clinician.Promoting transplantation tolerance; adoptive regulatory T cell therapy.Endothelium and regulatory inflammatory mechanisms during organ rejection.Transplant tolerance: new insights and strategies for long-term allograft acceptance.The expanding horizon of immunotherapy in the treatment of malignant disorders: allogeneic hematopoietic stem cell transplantation and beyond.New cell sources for T cell engineering and adoptive immunotherapy.Strategies for improving the efficacy of donor lymphocyte infusion following stem cell transplantation.Pathogenesis of the intravertebral vacuum of Kümmell's diseaseBiomarkers of acute rejection following cardiac transplantation.Chimeric Antigen Receptors: A Cell and Gene Therapy Perspective.Integration of a CD19 CAR into the TCR Alpha Chain Locus Streamlines Production of Allogeneic Gene-Edited CAR T Cells.The Human Mesenchymal Stromal Cell-Derived Osteocyte Capacity to Modulate Dendritic Cell Functions Is Strictly Dependent on the Culture System.Immune attributes of cardiac-derived adherent proliferating (CAP) cells in cardiac therapy.Immunomodulatory activity of glycodelin: Implications in allograft rejection.Acute and Chronic Rejection After Liver Transplantation: What A Clinician Needs to Know.Alloimmune T cells in transplantation.
P2860
Q26744359-0D6A9CAB-B2B5-4EDA-AF77-D2C43FBC687EQ26784256-4BF6DC1B-2EF0-492A-AEFC-73DB76207B4FQ26786188-AD09A469-66D4-46D3-82C4-325949B2410DQ27646543-198DD7E8-18D3-46E8-ACFB-09D64691962DQ30503251-A034E07D-2755-4D85-9008-B676D49CDE24Q33336577-510063A6-D7B2-4E6D-908F-177DC9704EB0Q33608371-98BAFA51-792A-4A10-9242-1E7486A728C6Q33750748-3CE95546-A00F-482F-AA49-20329458CCAEQ33804489-68372C93-9AC7-4793-8F0C-BDFDDFDC96B3Q33873407-8F60FECE-0422-46E9-BBF7-49444F390A0BQ35079104-C22D4B0A-0A7A-4F60-A1F4-C7BE1CEDADCFQ37211290-73885B78-36EB-405F-98A9-0CDEDB19323EQ37236992-16746B45-E6DB-4663-971E-A71484CC94E7Q37262486-D27750A5-FF08-455D-BC83-41F4096DF4C5Q37400370-95F1507D-6986-4223-A568-62A66DE48176Q37590051-DDA3924B-0DAB-4E43-8A62-EC998B424271Q37662989-9E03E476-7B04-4AAB-8C54-277FDB4F39A7Q37729059-40A5D9B8-650B-4CB1-AC44-7CA1CB870E7DQ37755212-ACA08E86-323B-4C57-8FA3-B41471E5EA36Q37869488-B29E98B2-5217-4F6B-837A-03110AB613AAQ37871065-FE4876DD-BBB1-4E4F-A494-AE3F349946BAQ37966022-3E17FD72-129B-4DB0-BC5E-0BE73912591FQ38027504-0A4177EE-4BD8-448E-89AA-C0D8840E30CDQ38040507-29653FA7-D52B-4A6A-9C79-CEA6F70FD5A0Q38053173-6624DF1D-7EB4-4BB3-B2E5-A6FC306418B2Q38097917-BEEDF5CD-A286-46CA-B736-CD3D7B8D6A47Q38103486-89EF50F8-E4C6-4517-9A67-7BDB6080DE49Q38114067-12A5676B-7A29-4F6E-A126-A71F428803CAQ38216836-DD16A95F-FA81-4089-A0E2-DDE1F0A2B258Q38406089-1EF8668F-1A9A-499D-9973-A8A7809EA133Q38660984-24360915-4E19-4FC6-A66F-3547E577C6DCQ38838938-D66F5407-6B7C-4706-B3C7-1E100936C892Q39128537-D34A28F1-9F85-412B-BC6D-B7AB1DD67C63Q39272183-A8388296-0386-40BC-A416-F237F97D4BBEQ40318331-AF850A69-7A3D-4DD7-914D-02C367C7B820Q42101420-453E710A-0D90-457E-A1B2-052FAF285F6DQ43652900-9EF07E70-5099-4BA4-8C70-1E124C673A7EQ47261448-3A070908-5857-4C4C-8E87-485CED16C72BQ49886138-0719A663-15BE-496D-8024-E236CCBA77C0Q50936985-40E25BA8-E56F-446D-A8C2-C32197F63318
P2860
Allorecognition and the alloresponse: clinical implications.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Allorecognition and the alloresponse: clinical implications.
@en
type
label
Allorecognition and the alloresponse: clinical implications.
@en
prefLabel
Allorecognition and the alloresponse: clinical implications.
@en
P2093
P2860
P1433
P1476
Allorecognition and the alloresponse: clinical implications.
@en
P2093
M P Hernandez-Fuentes
R I Lechler
P2860
P304
P356
10.1111/J.1399-0039.2007.00834.X
P577
2007-06-01T00:00:00Z